Dexcom Inc DXCM
Dividend Summary
There have not been any declared dividends recently.
Summary | Previous dividend | Next dividend |
---|---|---|
Status | – | – |
Type | – | – |
Per share | – | – |
Declaration date | – | – |
Ex-div date | – | – |
Pay date | – | – |
Enter the number of Dexcom Inc shares you hold and we'll calculate your dividend payments:
Sign up for Dexcom Inc and we'll email you the dividend information when they declare.
Add Dexcom Inc to receive free notifications when they declare their dividends.
Your account is set up to receive Dexcom Inc notifications.
Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
---|---|---|---|---|---|---|---|---|
There are no Dexcom Inc dividends. |
Year | Amount | Change |
---|---|---|
2006 | 0.0c | — |
2007 | 0.0c | 0% |
2008 | 0.0c | 0% |
2009 | 0.0c | 0% |
2010 | 0.0c | 0% |
2011 | 0.0c | 0% |
2012 | 0.0c | 0% |
2013 | 0.0c | 0% |
2014 | 0.0c | 0% |
2015 | 0.0c | 0% |
2016 | 0.0c | 0% |
2017 | 0.0c | 0% |
2018 | 0.0c | 0% |
2019 | 0.0c | 0% |
2020 | 0.0c | 0% |
2021 | 0.0c | 0% |
2022 | 0.0c | 0% |
2023 | 0.0c | 0% |
2024 | Sign Up Required |
Dexcom Inc Optimized Dividend Chart
- Dividend Yield Today
- 0.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 0.0% on 08 December 2023
- 52 Week Low
- 0.0% on 08 December 2023
- Next Ex-Div-Date Countdown
- Sign Up Required
About Dexcom Inc
Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- United States
- Share Price
- $77.72 (yesterday's closing price)
- Shares in Issue
- 391 million
- Market Cap
- $30.4bn
- 0
- Market Indices
- S&P 500
- Home Page URL
- https://www.dexcom.com/en-IE